Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies 27 February
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association Clinical & Scientific Conference 26 February
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders 23 February
